Kevin Fitzgerald, MD
Family Medicine · Stuart, FLNPI 1891923744
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $196,735 of the $197,634 with a category attached, or 99.5%. CSL Behring accounts for 63.6% of it on its own, with 8 other manufacturers making up the rest. Among family medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 166 payments — averaging $1190.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$126K
- CSL Plasma Inc.$71K
- Johnson & Johnson$524
- AMAG Pharmaceuticals, Inc.$125
- Seagen Inc.$92
- Sumitomo Pharma America, Inc.$69
- plus $89 from 3 others
What the payments were for
- Consulting fees$196,735100%
- Food & beverage$8990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 101 | $125,725 |
| CSL Plasma Inc. | 49 | $71,010 |
| Johnson & Johnson | 8 | $524 |
| AMAG Pharmaceuticals, Inc. | 1 | $125 |
| Seagen Inc. | 1 | $92 |
| Sumitomo Pharma America, Inc. | 3 | $69 |
| AstraZeneca | 1 | $50 |
| 180 Medical, Inc. | 1 | $25 |
| Pfizer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$197,634 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 32 | $533 |
| Cyclobenzaprine Hcl | 46 | $227 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Stuart
- Paul GambinoStuart$156K
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
- Samuel GreenleePensacola$235K
- Louis KuritzkyGainesville$186K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.